Gao Y, Cornfield D, Stenmark K, Thebaud B, Abman S, Raj J
Pulm Circ. 2016; 6(4):407-425.
PMID: 27942377
PMC: 5130074.
DOI: 10.1086/688890.
Zhang J, Jiang R, Liu L, Watkins T, Zhang F, Dong J
J Neurotrauma. 2012; 29(17):2597-605.
PMID: 23020190
PMC: 3510447.
DOI: 10.1089/neu.2012.2348.
Fong J, GOOD R
J Exp Med. 1971; 134(3 Pt 1):642-55.
PMID: 15776567
PMC: 2139067.
DOI: 10.1084/jem.134.3.642.
Chao W, Olson M
Biochem J. 1993; 292 ( Pt 3):617-29.
PMID: 8391253
PMC: 1134157.
DOI: 10.1042/bj2920617.
Ambrosio G, Oriente A, Napoli C, Palumbo G, Chiariello P, Marone G
J Clin Invest. 1994; 93(6):2408-16.
PMID: 8200975
PMC: 294448.
DOI: 10.1172/JCI117248.
Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
Sirois M, de Lima W, De Brum Fernandes A, Johnson R, Plante G, Sirois P
Br J Pharmacol. 1994; 111(4):1111-6.
PMID: 8032597
PMC: 1910145.
DOI: 10.1111/j.1476-5381.1994.tb14859.x.
Platelet activating factor: an inhibitor of neutrophil activation?.
ODONNELL M, Siegel J, Fiedel B
Clin Exp Immunol. 1981; 43(1):135-42.
PMID: 7249391
PMC: 1537118.
1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.
OFlaherty J, Wykle R, Miller C, Lewis J, Waite M, Bass D
Am J Pathol. 1981; 103(1):70-8.
PMID: 7223864
PMC: 1903803.
Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.
McManus L, HANAHAN D, Pinckard R
J Clin Invest. 1981; 67(3):903-6.
PMID: 7204562
PMC: 370642.
DOI: 10.1172/jci110108.
Aggregation of equine platelets by PAF (platelet-activating factor).
Suquet C, Leid R
Inflammation. 1983; 7(2):197-203.
PMID: 6862593
DOI: 10.1007/BF00917823.
Platelet serotonin release by human polymorphonuclear leucocytes stimulated by cotton dust bacteria.
Holt P, Holt B, Beijer L, Rylander R
Clin Exp Immunol. 1983; 51(1):185-90.
PMID: 6831770
PMC: 1536758.
Platelet-activating factor (PAF) as a mediator of neutrophil-platelet interactions in inflammation.
Henson P
Agents Actions. 1981; 11(6-7):545-7.
PMID: 6803533
DOI: 10.1007/BF01978732.
Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils.
Sanchez-Crespo M, Alonso F, Egido J
Immunology. 1980; 40(4):645-55.
PMID: 6776037
PMC: 1458111.
Platelets in the synovial fluid of patients with rheumatoid arthritis.
Farr M, Wainwright A, Salmon M, Hollywell C, Bacon P
Rheumatol Int. 1984; 4(1):13-7.
PMID: 6718950
DOI: 10.1007/BF00683878.
Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs.
Kenzora J, Perez J, Bergmann S, Lange L
J Clin Invest. 1984; 74(4):1193-203.
PMID: 6480824
PMC: 425285.
DOI: 10.1172/JCI111528.
Biology and biochemistry of platelet-activating factor.
OFlaherty J, Wykle R
Clin Rev Allergy. 1983; 1(3):353-67.
PMID: 6370406
DOI: 10.1007/BF02991226.
Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes.
Lin A, MORTON D, Gorman R
J Clin Invest. 1982; 70(5):1058-65.
PMID: 6290535
PMC: 370318.
DOI: 10.1172/jci110693.
Factors influencing immune complex localisation.
Schrieber L, Penny R
Rheumatol Int. 1984; 4(3):95-109.
PMID: 6235569
DOI: 10.1007/BF00541177.
Haemophilus influenzae and the beta-adrenergic system: a review.
Schreurs A, Nijkamp F
Vet Res Commun. 1984; 8(1):1-14.
PMID: 6202047
DOI: 10.1007/BF02214689.
A study of allograft kidney rejection occurring simultaneously in whole organ and ear chamber grafts in the rabbit.
Hobbs J, CLIFF W
J Exp Med. 1973; 137(3):776-98.
PMID: 4570018
PMC: 2139372.
DOI: 10.1084/jem.137.3.776.